Daniel Knott
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 10
- Co-authors
- Francisco Javier Salguero (1 shared paper)Victoria Graham (1 shared paper)Jane A. Potter (1 shared paper)Roger Hewson (1 shared paper)Stuart Dowall (1 shared paper)
- Journals
- The Lancet (3 papers)Nature Medicine (2 papers)Nature Communications (2 papers)Viruses (1 paper)PLoS Pathogens (1 paper)
- Partner nations
- United KingdomChinaBangladesh
In The Last Decade
Daniel Knott
10 papers receiving 7.3k citations
Daniel Knott's Hit Papers
Peers
Comparison fields: 5 of 99
- Infectious Diseases 4.7k
- Modeling and Simulation 214
- Health 269
- General Dentistry 5
- Toxicology 39
Countries citing papers authored by Daniel Knott
This map shows the geographic impact of Daniel Knott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Knott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Knott more than expected).
Fields of papers citing papers by Daniel Knott
This network shows the impact of papers produced by Daniel Knott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Knott. The network helps show where Daniel Knott may publish in the future.
Co-authors
The 5 scholars most cited alongside Daniel Knott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3698 |
| 2 | Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Hit paper breakdown → | 2020 | 1939 |
| 3 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 894 |
| 4 | 2020 | 481 | |
| 5 | 2020 | 257 | |
| 6 | 2021 | 124 | |
| 7 | 2021 | 118 | |
| 8 | 2023 | 10 | |
| 9 | 2024 | 8 | |
| 10 | 2023 | 2 |
About Daniel Knott
Daniel Knott is a scholar working on Infectious Diseases, Nuclear Energy and Engineering, Waste Management and Disposal, Organic Chemistry and Surgery, having authored 10 papers that have together received 7.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers). The work is most often cited by research in Infectious Diseases (4.7k citations), Modeling and Simulation (214 citations), Health (269 citations), General Dentistry (5 citations) and Toxicology (39 citations). Daniel Knott has collaborated with scholars based in United Kingdom, China and Bangladesh. Frequent co-authors include Francisco Javier Salguero, Victoria Graham, Jane A. Potter, Roger Hewson and Stuart Dowall. Their work appears in journals such as The Lancet, Nature Medicine, Nature Communications, Viruses and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.